• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.11%

    More On UGNEQ

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Unigene Laboratories Inc. (UGNEQ)

    -Other OTC
    0.00 Up 0.00(12.50%) Jul 7, 3:45PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012
    Total Revenue 614   1,537   3,413   2,738  
    Cost of Revenue1,636  111  830  452  
    Gross Profit (1,022) 1,426   2,583   2,285  
    Operating Expenses
    Research Development851  1,518  1,154  1,379  
    Selling General and Administrative2,504  2,866  3,116  2,843  
    Non Recurring984   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (5,361) (3,041) (1,687) (1,937)
    Income from Continuing Operations
    Total Other Income/Expenses Net11,861  (9,317)650  (6,027)
    Earnings Before Interest And Taxes6,500  (18,661)5,293  (7,964)
    Interest Expense4,521  4,244  3,465  3,282  
    Income Before Tax1,979  (22,905)1,828  (11,246)
    Income Tax Expense -  (1,288)54  (0)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops1,979  (21,674)1,774  (11,246)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 1,979   (15,341) (4,502) (11,246)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 1,979   (15,341) (4,502) (11,246)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.